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Abstract
Introduction: The appearance of vascular anomalies in the orofacial area is a common condition, which represents 
about 50% of these malformations. Traditional treatment approach, such as surgery and chemical sclerosis has 
been given way to a few less-invasive options, as the use of the 810nm diode laser to induce the sclerosis of the 
venous malformation by intralesional photocoagulation.  
Objectives: The objective of this study was to determine the efficacy of the diode laser in the intralesional treat-
ment of the orofacial venous malformations (OFVM), describing the recommended surgical approach, as well as 
to report the main associated complications. 
Patients and Methods: 10 cases of OFVM, diagnosed and treated at the Oral Surgery Department of the Dental 
Clinic of the University of Barcelona, between January, 2009 and April, 2011. Every case was treated under local 
anesthesia, performing at least one intralesional session of diode laser, applying an 1W active optic fiber, in con-
tinuous mode, inserted into the interior of the lesion through an intramuscular needle, from the deepest portion 
to the surface of the lesion. Postoperative medication was indicated and follow-up visits were perform during a 
period of at least 6 months. 
Results: Of a total of 10 cases of OFVM, mean age of 25.4 years, 8 required just a single session with intralesional 
laser diode, before the clinical verification of a total reduction of size of the lesion. In 2 of these cases, were needed 
at least 2 sessions of intralesional photocoagulation to reach a satisfactory cosmetic result. No complications of 
any kind occurred. After a follow-up period of at least 6 months only a case of recurrence was described.
Álvarez-Camino JC, España-Tost AJ, Gay-Escoda C.  Endoluminal scle-
rosis with diode laser in the treatment of orofacial venous malformations. 
Med Oral Patol Oral Cir Bucal. 2013 May 1;18 (3):e486-90. 
http://www.medicinaoral.com/medoralfree01/v18i3/medoralv18i3p486.pdf
Article Number: 18528          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.18528
http://dx.doi.org/doi:10.4317/medoral.18528
Med Oral Patol Oral Cir Bucal. 2013 May 1;18 (3):e486-90.                                                                                                                       Endoluminal treatment of orofacial venous malformations
e487
Discussion and Conclusions: The advantages associated to the use of non-invasive techniques in the treatment of 
OVM, along with the success rate and low number of relapses, shows the use of the diode laser as a therapy to be 
considered in the treatment of these lesions. A higher case mix would be essential for definitive conclusions.
Key words: Diode laser, hemangioma, orofacial venous malformation.
Introduction
Treatment of patients with vascular anomalies in the 
craniofacial area usually represents a major clinical 
challenge because 60% of these cases occur in young 
patients (1). Interdisciplinary diagnosis and treatment 
becomes of real importance in these cases. One of the 
main problems of the clinician at the time he had to deal 
with one of these cases, was the need of get a satisfactory 
classification of the lesion. In 1982, Mulliken and Glow-
acki (2) proposed a classification of vascular anomalies 
based on their clinical, histological and histochemical 
study. The classification of Mulliken and Glowacki 
groups the vascular anomalies into two major groups. 
The first group includes those tumors associated with 
a process of endothelial cell proliferation, which ap-
pears in childhood, with proliferative changes, followed 
by an involutional process of unknown etiology, called 
hemangiomas, and a second group consisting of those 
vascular malformations (VM) that appears as a result of 
the altered development and formation of blood vessels, 
present at the birth , normal endothelial mitotic activity, 
which grows with the individual and with no presence 
of an involutional process (2). These malformations can 
show any combination of capillary, venous, arterial or 
lymphatic components, presence or absence of fistula. 
Moreover, lesions can be differentiated according to the 
vascular flow, either low or high flow. Approximately 
50% of these vascular lesions are located at the head and 
neck region (3).
Different methods of treatment of vascular lesions has 
been described: surgery, steroid therapy, embolization, 
cryosurgery, electrodesiccation, among others (4). The 
use of intralesional injections of sclerosing agents is 
also showed as an effective method in the treatment of 
VM. During the 90’s, the use of high power lasers in 
the treatment of vascular abnormalities is introduced, 
with the use of neodymium: yttrium aluminum garnet 
contaminated with neodymium (Nd: YAG) laser, which 
proved to be an effective treatment tool, although with 
limitations (4). Photocoagulation using laser Nd: YAG 
as a method of treatment of vascular lesions is based on 
the high capacity of absorption of light by hemoglobin, 
which in conjunction with the heat released by the ab-
sorption of laser light during the penetration of the tis-
sues, produces a selective coagulation of the affected 
blood vessels.
The diode laser (GaAs, GaAlAs) is presented as an ef-
ficient, compact and portable surgical equipment, and 
represents a minor financial investment compared with 
other lasers equipments for surgical use. Diode lasers 
have a wavelength of between 805 to 980 nm. Can be 
used in both continuous and pulsed mode, as well as in 
contact or non-contact mode with the tissues, depend-
ing on the clinical indication. Applications in the non-
contact mode are performed using different fibers or by 
focalization the handpiece, as in the case of the coagula-
tion of superficial lesions or the excision of soft tissue 
lesions (5).
Sclerosis photocoagulation by diode laser has been used 
extensively in the treatment of VM in areas such as der-
matology and ophthalmology. Coagulation properties of 
the diode laser are particularly effective and beneficial 
in the treatment of VM (3). The diode laser light turns 
into heat because of its absorption by the hemoglobin. 
The penetration depth of the 810 nm wavelength  ap-
pears to be lower than the one in the Nd:YAG, allowing 
it use in an effective way in the coagulation of superfi-
cial and interstitial lesions (5). Histological studies on 
vein walls in which a diode laser session was applied 
revealed that a coagulative necrosis took place, show-
ing tissue distortion, not at the inner lining of the vessel 
only, but in outer layers of the vascular wall as well (5).
The objectives of this study are, using the report of cases 
treated in our department, to determine the efficacy of 
diode laser (λ 810nm) in the intralesional treatment of 
orofacial vascular malformations (OFVM), describe the 
surgical technique used, and report major complications.
Patient and Methods
A retrospective observational study of patients affected 
by OFVM was performed. These patients, who attended 
to the Oral Surgery Department of the Dental Clinic of 
the University of Barcelona, were diagnosed following 
the correspondent clinical criteria and were treated by 
using the intralesional sclerosis with diode laser dur-
ing the period between January, 2009 and April, 2011. 
All cases were identified through clinical diagnosis. 
No complementary diagnostic tests were run, except in 
those cases where the size of the lesion was significant 
enough to suspect a deep affectation of the surround-
ing tissues, and to discard the existence of intraosseous 
shunts, when the injury was settled in the vicinity of 
cortical bone.
OFVM of all the patients were treated using a 810 nm 
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wavelength gallium arsenide (GaAs) diode laser unit 
(Biolase ® LaserSmile ™, Biolase Technology, Inc., 
Irvine, USA.), using a 300μm optical fiber, preceded 
by perilesional anesthetic. All patients were treated in 
ambulatory settings, following the security protocol re-
lated to the use of a type IV laser.
The information was collected by a single observer; 
age, gender, size and localization of the lesion and post-
operative follow up data were collected.
The data was processed using the Statistical Package for 
Social Sciences version 12.0 (SPSS, SPSS Inc., Chicago, 
Ill, USA, licensed to the University of Barcelona).
Results
A total of 10 patients, mean age of 25.4 years, age range 
from 19 to 39, with a predominance of female patients 
(7:3) was reported. 80% (n = 8) of these patients pre-
sented OFVM lesions with a diameter of 3 cm (mean= 
3.1 cm) or less. The upper lip (50%) was the most fre-
quent location, followed by the dorsum of tongue (20%) 
(Table 1).
Patient Age Gender Location Diameter Number of sessions Recurrence
1 19 M Dorsum of tongue 5.4 cm 2 Yes
2 31 F Upper lip 3 cm 1 No
3 23 F Upper lip 2.9 cm 1 No
4 26 M Jugal Mucosa 1 cm 1 No
5 19 F Labial commis-sure 2.4 cm 1 No
6 39 M Upper lip 3 cm 1 No
7 38 F Upper lip 6.1 cm 3 No
8 21 F Dorsum of tongue 3 cm 1 No
9 23 F Lower lip 2.3 cm 1 No
10 30 F Upper lip 2.1 cm 1 No
Table 1. Clinical data of the OFVM included in the study.
The surgical technique begins with a perilesional infil-
tration of 4% articaine hydrochloride  with epinephrine 
1:100000, followed by the puncture of the lesion with a 
20G angiocatheter (Abbocath, Abbott Laboratories, Il-
linois, USA) as initial approach, followed by the intro-
duction of the previously activated optical fiber, via the 
catheter lumen until the active tip is positioned within 
the OFVM , keeping it accessible using the lighting 
guide of the laser unit. The laser is radially applied in 
the deeper areas of the lesion, while the laser fiber is 
progressively moved upward to the entrance area of the 
fiber. Subsequently, the optical fiber is removed and 
postoperative instructions are given; analgesic medica-
tion (paracetamol 1 g, one tablet every 8 hours for 4 
days) and topical 0.2% chlorhexidine bioadhesive gel 
(2 times a day, every 12 hours for 15 days) is recom-
mended. Follow-up visits are performed at 7, 30, 180 
and 365 days.
80% of the treated OFVM required a single session of 
intralesional endoluminal treatment to completely re-
move the lesion, this was confirmed during the follow-
up visits. Lesions with a diameter less than or equal to 3 
cm required a single session. It was found that, in a case 
of OFVM (10%) located in the upper lip, diameter of 
6.1 cm, although there was a significant reduction in the 
lesion size, there was not a complete involution of the 
lesion after 7 and 30 days postoperative evaluations, so 
it was decided that a second session with intralesional 
diode laser had to be performed. After a 30 days fol-
low-up visit, an incomplete involution of the lesion was 
observed, so it was decided to perform a third session. 
During a follow up visit after the latter approach, it was 
found an important involution of the lesion, although 
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the aesthetic commitment remained. The recurrence 
of the lesion has been described In one case (10%), af-
ter the 180 days follow-up visit. The lesion, located on 
the dorsal side of the tongue, presented an initial total 
involution observed after the first follow-up visits. Af-
ter a second treatment session, and 7, 30 and 180 days 
follow-up visits, the complete regression of the lesion 
was observed.
Discussion
Back in 1996, the International Society for the Study 
of Vascular Anomalies adopted the classification pro-
posed by Mulliken and Glowacki, which classifies the 
vascular lesions in tumors (hemangiomas, etc.) and 
malformations (capillary, venous, arteriovenous, lym-
phatic, combined) (2). Hemangiomas, with its char-
acteristic endothelial structure, tend to an after birth 
development, with an increasing tendency to grow 
during the first year of life, followed by a slow regres-
sion, presenting a complete evolution at 4 or 5 years 
in 50% of cases  (1,4). Due to this fact, a passive atti-
tude is recommended, performing regular follow-ups. 
Vascular malformations, on the other hand, are usually 
diagnosed at birth, grow with the individual, and show 
no tendency to regress on their own(1). Most authors 
report a relatively high incidence of OFVM (3). 50% of 
all benign lesions appear on the head and neck area(4), 
causing discomfort to the patient by its functional and 
aesthetic impact.
The diagnosis of venous malformation (VM), as well 
as of vascular tumors is usually based on their clinical 
features. High risk of bleeding during is the biopsy plus 
the benignity of the lesions, advise against conducting a 
histopathology study, despite being histologically differ-
ent entities. However, the different treatment modalities 
described by the authors are similar for both entities.
Different therapeutic options are used in the treatment 
of benign vascular lesions. The choice will depend on 
the location, depth and the progression of the lesion. No 
treatment is necessary in a few cases; in the other hand, 
the lesion could be associated with serious sequelae 
such as growth, bleeding or cause critical airway ob-
struction, which would require immediate surgery (6).
In the case of hemangioma, periodic controls are in-
cluded as a treatment option. This is because the lesion 
invariably regresses, and in some cases may remit com-
pletely, but frequent controls are recommended to eval-
uate the evolution of the lesion. In the case of small VM 
control may be an option, although there is controversy 
about the need of treatment (7). Surgical resection is 
complicated, and is associated with an increased risk of 
bleeding, difficulty of anatomical dissection, scarring 
sequelae, deformity and a high rate of recurrence (3). 
Cryosurgery can be a treatment option for early stages 
of some small, superficial vascular lesions, but carries 
a risk of atrophy, hypopigmentation and scarring in the 
skin of treated area (8).
One of the most commonly employed treatments for VM 
consists of intralesional injection of substances such as 
absolute ethanol and other sclerosing agents such as 
sodium morrhuate polidocanol (9). The mechanism of 
action is based on the damage of the endothelium, with 
a consequent inflammation process and the subsequent 
associated fibrosis. Despite this, and though is a highly 
protocolized technique, with a 70-90% success rate 
when performed by an experienced team, sequelae and 
complications have been described, such as cutaneous 
or mucosal necrosis, and peripheral nerve injury (3).
The use of different types of lasers in the treatment of 
vascular lesions was discussed in early studies such the 
one of Apfelger and Maser (10), that suggested that in-
tralesional therapy using the Nd:YAG laser can be an 
effective treatment the MV. Initially, the Nd:YAG laser 
was used in the treatment of hemangiomas and VM by 
irradiating the surface of the lesion, in continuous mode 
to get the sclerosis of the lesion without puncturing; 
however, this technique is associated to  necrosis of the 
irradiated area, due to the high capacity of tissue pen-
etration presented in this type of laser, therefore, this 
technique requires the continuous local application of 
cold to avoid necrosis (5).
The diode laser has a selective performance over vascu-
lar tissues. It works in a 810-980 nm wavelength range, 
exhibiting a selective absorption by hemoglobin, with a 
tissue penetration as low as 0.3 mm, due to its high affin-
ity for water, which forms 80% of the soft tissues  (11,12). 
The intralesional fiber of the diode laser seeks to cause 
the endothelial injury of the affected vessel by both the 
thermal action caused by laser light, and the secondary 
thermal effect caused by the bubbles associated with the 
absorption of light energy by hemoglobin (13).
Different authors, like Angiero et al. (7), Lapidoth et al. 
(14), Genovese et al. (15), Puche-Torres et al. (3), per-
form the endoluminal sclerosis technique for both MV 
or hemangiomas at the orofacial area. Lapidoth et al. 
(14) even combines intralesional use of diode laser with 
radiofrequency, with a success rate of 90%, with few 
postoperative complications. Overally speaking, the 
success rate of treatment of MV with intralesional laser 
diode is positive, according to the published casuistry, 
especially in small superficial lesions. A success rate of 
95.24% for one or two sessions of treatment is referred 
by Puche-Torres et al. (3).
Different investigators also report the recurrence of the 
VM after treatment with endoluminal sclerosis using 
the diode laser, although the incidence rate is quite low. 
Puche-Torres et al. (3) reported a recurrence rate of 4.76%. 
In our study, a single case of recurrence is reported.
The highest rate of complications is associated with an 
inadequate transfer of energy to the surrounding tis-
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sues, as in any technique in which laser is used. Ex-
treme caution should be taken with mucous membranes 
and skin next to the OFVM. Injury can also occur in 
structures near the VM, such as nerves or excretory 
ducts. This circumstance should be taken into account 
during the treatment planning, and alternative methods, 
such as cryosurgery should be considered (7). To avoid 
these complications, an adequate safety margin should 
be keep, relative to the size of the lesion, trying not to 
keep the laser fiber too long at the same place, moving 
slowly within the lesion, observing the decrease in size 
and bleaching of the lesion.
Other lasers can achieve better success rates, because 
of its better absorption by hemoglobin. These include 
the argon laser and Nd: YAG KTP. Both emit a green 
light that matches the peak of maximum absorption of 
the hemoglobin.
Conclusions
Treatment of OFVM by endoluminal diode laser is a 
practical technique, fast, simple, minimally invasive, 
performed under local anesthesia in an outpatient set-
ting, with a low complication rate, with an excellent 
postoperative results, whenever an experienced and 
trained clinician is on the lead.
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